(Q35082545)

English

Plasmacytoma-like post-transplant lymphoproliferative disorder, a rare subtype of monomorphic B-cell post-transplant lymphoproliferation, is associated with a favorable outcome in localized as well as in advanced disease: a prospective analysis of 8

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Plasmacytoma-like post-transplant lymphoproliferative disorder, a rare subtype of monomorphic B-cell post-transplant lymphoproliferation, is associated with a favorable outcome in localized as well as in advanced disease: a prospective analysis of 8 (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

post-transplant lymphoproliferative disorder

0 references

4

object named as

Petra Reinke

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Martin Dreyling

5

object named as

Martin Dreyling

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

author name string

Ralf Trappe

1

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Heiner Zimmermann

2

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Susanne Fink

3

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Andreas Pascher

6

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Hans Lehmkuhl

7

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Barbara Gärtner

8

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Ioannis Anagnostopoulos

9

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Hanno Riess

10

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

publication date

1 July 2011

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

96

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

1067-1071

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Multicenter analysis of 80 solid organ transplantation recipients with post-transplantation lymphoproliferative disease: outcomes and prognostic factors in the modern era.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3128229

8 July 2018

Prospective study of sequential reduction in immunosuppression, interferon alpha-2B, and chemotherapy for posttransplantation lymphoproliferative disorder.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3128229

8 July 2018

Association between elevated whole blood Epstein-Barr virus (EBV)-encoded RNA EBV polymerase chain reaction and reduced incidence of acute lung allograft rejection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3128229

8 July 2018

Post-transplant plasma cell myeloma and polymorphic lymphoproliferative disorder with monoclonal serum protein occurring in solid organ transplant recipients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3128229

8 July 2018

Epstein-Barr virus load monitoring: its role in the prevention and management of post-transplant lymphoproliferative disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3128229

8 July 2018

Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: analysis of prognostic variables and long-term follow-up of 42 adult patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3128229

8 July 2018

Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3128229

8 July 2018

Epstein-Barr virus DNA in peripheral blood leukocytes of patients with posttransplant lymphoproliferative disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3128229

8 July 2018

Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3128229

8 July 2018

Malignant lymphomas in transplantation patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3128229

8 July 2018

Thoracic and abdominal manifestations of lymphoma occurring in the immunocompromised patient

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3128229

8 July 2018

Effect of anti-CD 20 antibody rituximab in patients with post-transplant lymphoproliferative disorder (PTLD).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3128229

27 September 2018

Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3128229

27 September 2018

Post-transplantation lymphoproliferative disease in heart and heart-lung transplant recipients: 30-year experience at Stanford University

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3128229

27 September 2018

Identification of prognostic factors in 61 patients with posttransplantation lymphoproliferative disorders.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3128229

27 September 2018

Serial measurement of Epstein-Barr viral load in peripheral blood in pediatric liver transplant recipients during treatment for posttransplant lymphoproliferative disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3128229

27 September 2018

The clinical and pathologic implications of plasmacytic infiltrates in percutaneous renal allograft biopsies

1 reference

https://pubmed.ncbi.nlm.nih.gov/21719885

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/21719885

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Posttransplant lymphoproliferative disorders: summary of Society for Hematopathology Workshop

1 reference

https://pubmed.ncbi.nlm.nih.gov/21719885

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CHOP-21 for the treatment of post-transplant lymphoproliferative disorders (PTLD) following solid organ transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/21719885

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospective phase II trial of extended treatment with rituximab in patients with B-cell post-transplant lymphoproliferative disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/21719885

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Extramedullary plasmacytoma-like posttransplantation lymphoproliferative disorders: clinical and pathologic features

1 reference

https://pubmed.ncbi.nlm.nih.gov/21719885

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Posttransplantation lymphoproliferative disorder of the abdomen: CT evaluation in 51 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/21719885

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3324/HAEMATOL.2010.039214

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35082545&oldid=2092773765"